Ming-Jai Su Selected Research

Cholesterol

5/2007	Apocynin alleviated hepatic oxidative burden and reduced liver injury in hypercholesterolaemia.
5/2004	Dietary cholesterol affects sympathetic nerve function in rabbit hearts.
5/2003	Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Jai Su Research Topics

Disease

10	Ischemia 01/2016 - 04/2002
10	Infarction (Infarctions) 05/2015 - 04/2002
9	Reperfusion Injury 05/2015 - 04/2002
6	Fibrosis (Cirrhosis) 01/2020 - 02/2014
5	Endotoxemia 12/2019 - 03/2006
5	Myocardial Ischemia (Ischemic Heart Diseases) 05/2015 - 03/2004
4	Myocardial Infarction 06/2014 - 12/2004
4	Atrial Fibrillation 01/2006 - 02/2003
3	Ventricular Tachycardia 01/2017 - 03/2003
3	Coronary Disease (Coronary Heart Disease) 03/2015 - 04/2002
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2014 - 10/2006
3	Cardiac Arrhythmias (Arrythmia) 07/2008 - 06/2003
3	Wounds and Injuries (Trauma) 05/2007 - 04/2002
2	Leukemia 01/2020 - 01/2012
2	Sepsis (Septicemia) 12/2019 - 03/2006
2	Heart Diseases (Heart Disease) 06/2018 - 12/2016
2	Chronic Renal Insufficiency 01/2017 - 07/2015
2	Heart Failure 09/2015 - 02/2008
2	Inflammation (Inflammations) 03/2015 - 05/2007
2	Necrosis 08/2013 - 01/2005
2	Type 2 Diabetes Mellitus (MODY) 06/2013 - 10/2006
2	Hypertension (High Blood Pressure) 01/2012 - 02/2003
2	Shock 12/2010 - 01/2005
2	Septic Shock (Toxic Shock Syndrome) 12/2010 - 03/2006
2	Hypotension (Low Blood Pressure) 03/2006 - 01/2005
2	Ventricular Fibrillation 01/2006 - 05/2003
1	Atrial Remodeling 01/2017
1	Hyperaldosteronism (Conn Syndrome) 01/2016
1	Hypertrophy 09/2015
1	Adenoma (Adenomas) 09/2015
1	Essential Hypertension 09/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Cardio-Renal Syndrome 07/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Ureteral Obstruction 03/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2014
1	ST Elevation Myocardial Infarction 03/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2014
1	Diastolic Heart Failure 02/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2004
5	AntioxidantsIBA 01/2016 - 04/2002
4	caffeic acidIBA 09/2015 - 01/2012
4	Streptozocin (Streptozotocin)FDA Link 06/2014 - 10/2006
4	thaliporphineIBA 12/2010 - 01/2005
3	oxidized low density lipoproteinIBA 01/2017 - 03/2014
3	CalciumIBA 07/2015 - 05/2003
3	KS370GIBA 03/2015 - 06/2012
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2014 - 12/2010
3	Hypoglycemic Agents (Hypoglycemics)IBA 06/2013 - 10/2006
3	CholesterolIBA 05/2007 - 05/2003
3	ResveratrolIBA 01/2007 - 04/2002
2	Rho Guanine Nucleotide Exchange FactorsIBA 01/2020 - 01/2012
2	CytokinesIBA 12/2019 - 03/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2019 - 12/2004
2	AldosteroneIBA 01/2016 - 09/2015
2	Free RadicalsIBA 01/2016 - 04/2002
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 06/2012
2	caffeic acid phenethyl esterIBA 03/2015 - 06/2014
2	CollagenIBA 03/2015 - 07/2014
2	Fibronectins (Fibronectin)IBA 03/2015 - 07/2014
2	AmidesIBA 07/2014 - 01/2012
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2014 - 03/2004
2	EndotoxinsIBA 12/2010 - 01/2005
2	3,3',4,5'-tetrahydroxystilbeneIBA 06/2009 - 04/2002
2	Doxazosin (Cardura)FDA LinkGeneric 07/2008 - 03/2008
2	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2008 - 03/2008
2	bunazosin (Andante)IBA 07/2008 - 03/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2006 - 03/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006 - 01/2005
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Anti-Arrhythmia AgentsIBA 12/2019
1	Toll-Like Receptor 4IBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	NF-kappa B (NF-kB)IBA 12/2019
1	IsoquinolinesIBA 12/2019
1	isoquinolineIBA 12/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2019
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 06/2018
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 09/2015
1	CatecholaminesIBA 09/2015
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2015
1	Lipoproteins (Lipoprotein)IBA 07/2015
1	1,10- dimethoxy- 6- (2- (2- methoxyphenoxy)ethyl)- 5,6,6a,7- tetrahydro- 4H- dibenzol(de,g)quinoline- 2,9- diy1 bis(dihydrogen phosphate)IBA 05/2015
1	salicylhydroxamic acid (SHAM)IBA 05/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2015
1	Metformin (Glucophage)FDA LinkGeneric 03/2015
1	Collagen Type I (Type I Collagen)IBA 03/2015
1	VimentinIBA 03/2015
1	EsterasesIBA 03/2015
1	Cadherins (E-Cadherin)IBA 07/2014
1	Plasminogen Activator Inhibitor 1IBA 07/2014
1	caffeic acid phenethyl amideIBA 06/2014
1	arginine methyl esterIBA 06/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2014
1	Connective Tissue Growth FactorIBA 02/2014

Therapy/Procedure

5	Therapeutics 12/2016 - 07/2004
1	Injections 09/2015
1	Adrenalectomy 09/2015
1	Intravenous Injections 06/2014